We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
251
FedEx
FDX
$75.4B
$2.25M 0.04%
9,880
-732
-7% -$160K
PFE icon
252
Pfizer
PFE
$153B
$2.24M 0.04%
92,345
-8,248
-8% -$192K
ASML icon
253
ASML
ASML
$669B
$2.2M 0.04%
2,750
-109
-4% -$78.2K
KLAC icon
254
KLA
KLAC
$259B
$2.2M 0.04%
24,600
+550
+2% +$41.4K
SPLV icon
255
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$2.19M 0.04%
30,117
-425
-1% -$30.8K
PWV icon
256
Invesco Large Cap Value ETF
PWV
$1.72B
$2.18M 0.04%
35,150
CMI icon
257
Cummins
CMI
$88.7B
$2.18M 0.04%
6,666
-118
-2% -$36.5K
MCO icon
258
Moody's
MCO
$82.7B
$2.18M 0.04%
4,347
-205
-5% -$95K
DVY icon
259
iShares Select Dividend ETF
DVY
$23.6B
$2.17M 0.04%
16,309
+271
+2% +$35.1K
IGEB icon
260
iShares Investment Grade Systematic Bond ETF
IGEB
$1.46B
$2.16M 0.04%
47,549
-19,319
-29% -$861K
FISV
261
Fiserv Inc
FISV
$27.9B
$2.13M 0.04%
12,328
+5,464
+80% +$991K
CERO
262
DELISTED
CERo Therapeutics
CERO
$2.12M 0.04%
220,000
+209,000
+1,900% +$2.6M
BAH icon
263
Booz Allen Hamilton
BAH
$9.15B
$2.1M 0.04%
20,187
+251
+1% +$28.1K
EEMV icon
264
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
$2.09M 0.04%
33,353
+3,522
+12% +$212K
XBI icon
265
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$2.08M 0.04%
25,129
-2,298
-8% -$183K
GWW icon
266
W.W. Grainger
GWW
$60.2B
$2.07M 0.04%
1,985
+314
+19% +$326K
IJT icon
267
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$2.04M 0.04%
15,366
+1,182
+8% +$148K
XLF icon
268
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$2.04M 0.04%
38,987
-313
-0.8% -$15.5K
HRL icon
269
Hormel Foods
HRL
$13.8B
$2.03M 0.04%
67,235
+113
+0.2% +$3.41K
HIG icon
270
Hartford Financial Services
HIG
$39.3B
$2.01M 0.04%
15,824
-280
-2% -$34.8K
SSNC icon
271
SS&C Technologies
SSNC
$18.6B
$1.99M 0.04%
24,017
-1,698
-7% -$133K
EMXC icon
272
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.1B
$1.99M 0.04%
31,459
-4,331
-12% -$252K
VBK icon
273
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
$1.98M 0.04%
7,163
+499
+7% +$128K
UPS icon
274
United Parcel Service
UPS
$88.9B
$1.98M 0.04%
19,609
+3,457
+21% +$340K
IWR icon
275
iShares Russell Mid-Cap ETF
IWR
$57.4B
$1.97M 0.04%
21,467
-970
-4% -$83.8K

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.